Asia Pacific Xerostomia Therapeutics Market Size & Outlook
Related Markets
Asia Pacific xerostomia therapeutics market highlights
- The Asia Pacific xerostomia therapeutics market generated a revenue of USD 425.5 million in 2024.
- The market is expected to grow at a CAGR of 5.1% from 2025 to 2030.
- In terms of segment, salivary stimulants was the largest revenue generating product in 2024.
- Dentifrices is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 425.5 million |
| Market revenue in 2030 | USD 570.8 million |
| Growth rate | 5.1% (CAGR from 2025 to 2030) |
| Largest segment | Salivary stimulants |
| Fastest growing segment | Dentifrices |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Salivary Stimulants, Salivary Substitutes, Dentifrices |
| Key market players worldwide | GlaxoSmithKline, Church & Dwight Co Inc, Colgate-Palmolive Co, Hikma Pharmaceuticals PLC, Pendopharm, Sun Pharmaceutical Industries, Lupin, Pfizer Inc, Parnell Pharmaceuticals Holdings Ltd, Acacia Pharma |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 19.7% of the global xerostomia therapeutics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 570.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Xerostomia Therapeutics Market Scope
Xerostomia Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Acacia Pharma | View profile | 51-100 | Cambridge, Cambridgeshire, United Kingdom, Europe | http://www.acaciapharma.com |
| Parnell Pharmaceuticals Holdings Ltd | View profile | 78 | 476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, Australia, 2015 | https://www.parnell.com |
| Pendopharm | View profile | 1001-5000 | Montreal, Quebec, Canada, North America | http://pendopharm.com |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| Hikma Pharmaceuticals PLC | View profile | 2150 | 1 New Burlington Place, London, United Kingdom, W1S 2HR | https://www.hikma.com |
| Colgate-Palmolive Co | View profile | 34000 | 300 Park Avenue, New York, NY, United States, 10022 | https://www.colgatepalmolive.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Church & Dwight Co Inc | View profile | 5550 | 500 Charles Ewing Boulevard, Ewing, NJ, United States, 08628 | https://www.churchdwight.com |
| Lupin | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | https://www.lupin.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
Asia Pacific xerostomia therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to xerostomia therapeutics market will help companies and investors design strategic landscapes.
Salivary stimulants was the largest segment with a revenue share of 37.04% in 2024. Horizon Databook has segmented the Asia Pacific xerostomia therapeutics market based on salivary stimulants, salivary substitutes, dentifrices covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Asia Pacific xerostomia therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific xerostomia therapeutics market databook
-
Our clientele includes a mix of xerostomia therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific xerostomia therapeutics market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific xerostomia therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific xerostomia therapeutics market size, by country, 2018-2030 (US$M)
Asia Pacific Xerostomia Therapeutics Market Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
